List of Excipients in API azelastine hydrochloride, fluticasone propionate
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing azelastine hydrochloride, fluticasone propionate
Detailed excipient profiles for azelastine hydrochloride, fluticasone propionate
Excipient focus: BENZALKONIUM CHLORIDE
azelastine hydrochloride, fluticasone propionate drug variants containing BENZALKONIUM CHLORIDE
azelastine hydrochloride, fluticasone propionate drug variants not containing BENZALKONIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM
azelastine hydrochloride, fluticasone propionate drug variants containing CARBOXYMETHYLCELLULOSE SODIUM
azelastine hydrochloride, fluticasone propionate drug variants not containing CARBOXYMETHYLCELLULOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
azelastine hydrochloride, fluticasone propionate drug variants containing CELLULOSE, MICROCRYSTALLINE
azelastine hydrochloride, fluticasone propionate drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Excipient focus: EDETATE DISODIUM
azelastine hydrochloride, fluticasone propionate drug variants containing EDETATE DISODIUM
azelastine hydrochloride, fluticasone propionate drug variants not containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERIN
azelastine hydrochloride, fluticasone propionate drug variants containing GLYCERIN
azelastine hydrochloride, fluticasone propionate drug variants not containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Excipient focus: PHENYLETHYL ALCOHOL
azelastine hydrochloride, fluticasone propionate drug variants containing PHENYLETHYL ALCOHOL
azelastine hydrochloride, fluticasone propionate drug variants not containing PHENYLETHYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
azelastine hydrochloride, fluticasone propionate drug variants containing POLYSORBATE 80
azelastine hydrochloride, fluticasone propionate drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
azelastine hydrochloride, fluticasone propionate drug variants containing WATER
azelastine hydrochloride, fluticasone propionate drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
